Ozmosi | Phenindione Drug Profile
Contact Us
Drug Search Results
Using advanced filters...
Advanced Search [+]

Phenindione

Alternative Names: phenindione, hedulin
Clinical Status: Inactive
Latest Update: 2021-05-24
Latest Update Note: Clinical Trial Update

Product Description

Phenindione is a beta-diketone and an aromatic ketone. It has a role as an anticoagulant.  (Sourced from: https://pubchem.ncbi.nlm.nih.gov/compound/Phenindione)

Mechanisms of Action: Vitamin K Antagonist

Novel Mechanism: No

Modality: Small Molecule

Route of Administration: Oral

FDA Designation: *

Approval Status: Approved

Approved Countries: Australia | Malta | Russia | Taiwan | Ukraine | United Kingdom | Venezuela

Approved Indications: None

Known Adverse Events: None

Company: Bayer
Company Location:
Company Founding Year: 1863
Additional Commercial Interests: None

Clinical Description

Countries in Clinic:

Active Clinical Trial Count:

Recent & Upcoming Milestones

Highest Development Phases

Phase 3: Pregnancy Outcomes|Intracranial Hemorrhage, Hypertensive|Ventricular Fibrillation|Ventricular Flutter|Cerebrovascular Disorders|Intracranial Hemorrhages|Atrial Flutter|Cerebral Hemorrhage|Subarachnoid Hemorrhage|Cerebral Small Vessel Diseases|Hematoma, Subdural, Intracranial|Atrial Fibrillation|Stroke

Trial ID

Trial

Phase

Trial Status

Disease

Primary Completion Date

Probability of Success

Latest Trial Update Date

Data Updated

NCT04099238

 BEST-AF

N/A

Completed

Atrial Fibrillation

2020-07-16

2020-08-08

2016-004121-16

 Start or STop Anticoagulants Randomised Trial (SoSTART)

P3

Unknown status

Stroke|Atrial Fibrillation

2022-09-11

2022-03-13

Treatments

NCT03153150

 SoSTART

P3

Completed

Cerebrovascular Disorders|Cerebral Hemorrhage|Ventricular Flutter|Intracranial Hemorrhage, Hypertensive|Cerebral Small Vessel Diseases|Intracranial Hemorrhages|Atrial Flutter|Hematoma, Subdural, Intracranial|Atrial Fibrillation|Ventricular Fibrillation|Subarachnoid Hemorrhage

2021-03-26

2021-05-25

Primary Completion Date|Primary Endpoints|Study Completion Date|Treatments|Trial Status

NCT01758640

 AINSHAMS2012

P3

Completed

Pregnancy Outcomes

2012-06-01

2019-03-19

Treatments

Recent News Events

Date

Type

Title

08/03/2020

News Article

 Phenindione (CAS 83-12-5) Market Research Report 2020 - ResearchAndMarkets.com

Did PRYZM just deliver the data you were looking for?
Did you try our Excel download too?

Now that you've used PRYZM, we hope you're able to see for yourself that it was designed and developed by people who actually use this data for a living. By applying next-generation technology for aggregating and curating this info across multiple key sources PRYZM delivering the latest information at your fingertips just the way you need it and with industry leading speed and cost effectiveness.

Our subscribers enjoy unlimited searches and receive this data on their own secure instance so they can overlay any additional internal/proprietary data on top of the search results and blend that data with real-time industry intel from PRYZM. Discover how you can continue to uncover the competitive landscape and drive strategy.

Suggestions